Study of Difluprednate Ophthalmic Emulsion in Postoperative Inflammation

NCT00406341 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Inflammation

Interventions

DRUG: Difluprednate Ophthalmic Emulsion

Sponsor

Sirion Therapeutics, Inc.